ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kineret receives positive CHMP opinion for treatment of COVID-19 pneumonia
December 17, 2021The European Medicines Agency has recommended approval for use of Kineret in COVID-19 to the European Commission, which will issue a final decision. -
Kineret® improves clinical outcomes in hospitalised patients with COVID-19 pneumonia
May 07, 2021Treating moderate to severe COVID-19 pneumonia patients with poor prognosis with Kineret® (anakinra) prevented death and progression to severe respiratory failure. -
Sobi launches Kineret for AOSD, SJIA
July 17, 2018Sobi UK and Ireland has announced the launch of Kineret across the country offering a new treatment option for Adult Onset Stills Disease (AOSD) and Systemic-Onset Juvenile Idiopathic Arthritis (SJIA).
Pharma Sources Insight January 2025
